Telomir Pharmaceuticals Inc. Common Stock

TELO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.25

+$0.01 (+0.81%)

At close: Sep 22, 2026, 4:00 PM ET

$1.24

-$0.01 (-0.80%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $85.28M

Enterprise Value $80.11M

Beta -0.25

Average Volume 134.24K

Shares Outstanding (Diluted) 60.84M

Shares Change YoY 102.72%

Institutional Ownership 6.52%

Exchange NASDAQ

ISIN US87975F1049

Price Performance

Price Change 1M 6.9%

Price Change 3M -0.8%

Price Change 6M -6.8%

Price Change YTD -7.5%

Price Change 1Y -20.5%

Price Change 3Y -75.2%

Price Change 5Y -75.2%

1M CAGR (ann.) 6.9%

1Y CAGR (ann.) -11.4%

5Y CAGR (ann.) N/A

All-Time CAGR -48.3%

Valuation

PE Ratio -1.36

Forward PE N/A

PEG Ratio 0.00

Forward PEG -0.02

PS Ratio N/A

Forward PS N/A

PB Ratio 16.94

P/FCF Ratio -17.35

P/Adj. FCF Ratio -19.33

P/OCF Ratio -8.86

EV/Sales N/A

EV/EBIT -19.30

EV/EBITDA -19.30

EV/FCF -16.30

Earnings Yield -73.4%

FCF Yield -5.8%

Adj. FCF Yield -5.2%

Financial Health

Net Cash $5.17M

Total Debt $0

Cash & Short-Term Investments $5.17M

Total Assets $5.37M

Current Ratio 16.14

Quick Ratio 16.14

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -867.98

Altman Z-Score 141.09

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -10.2%

Returns

Return on Assets -109.5%

Return on Equity -102.7%

Return on Invested Capital -120.9%

Return on Capital Employed -120.9%

Return on Tangible Assets -109.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -17.8%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y 16.8%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 19.8%

Revenue Growth Next 3Y N/A

Earnings Date Dec 1, 2026

EPS Estimate (next Q) -$0.03

EPS Growth Est (next Q) 0.0%

Revenue Est (next Q) $500K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $4

Price Target Upside 222.6%

Cash Flow

Operating Cash Flow $-4.91M

Free Cash Flow $-4.91M

Adj. Free Cash Flow $-4.41M

FCF Per Share -$0.14

OCF Per Share -$0.14

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-4.32M

EBITDA $-4.15M

Net Income $-51.99M

EPS (Diluted) -$0.91

Revenue / Employee N/A

Profit / Employee $-25.99M

Employees 2